0.38
+0.04(+11.76%)
Currency In HKD
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1131
First IPO Date
July 11, 2018
| Name | Title | Pay | Year Born |
| Mr. Zhiming Cao | Chief Executive Officer & Executive Chairman | 2.13M | 1986 |
| Ms. Qingfen Meng | Executive Director | 84,544 | 1965 |
| Mr. Taisheng Hou | Executive Director | 88,879 | 1963 |
| Mr. Yongsheng Chi | Executive Director | 92,131 | 1962 |
| Mr. Yuk Hong Yeung | Company Secretary | 0 | 1991 |
| Mr. Zhen Li | Chief Financial Officer | 0 | 1978 |
Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China. The company's product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; and flunarizine hydrochloride capsules and compound ferrous sulfate granules, as well as Yuanhu Zhitong oral solutions, Ganweikang tablets, and Yixinkang tablets. In addition, it researches, develops, produces, and sells various proprietary Chinese medicines and western medicine products for the treatment of cold and fever, cardiovascular diseases, and anemia. Further, the company offers business management and consulting services. Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.